Method of treating cell proliferative disorders using growth hormone secretagogues

Details for Australian Patent Application No. 2008216789 (hide)

Owner Helsinn Therapeutics (U.S.), Inc.

Inventors Polvino, Williams J.

Agent Spruson & Ferguson

Pub. Number AU-A-2008216789

PCT Pub. Number WO2008/100448

Priority 60/901,609 13.02.07 US

Filing date 8 February 2008

Wipo publication date 21 August 2008

International Classifications

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/100448 Priority application(s): WO2008/100448

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008216794-Methods of use of glycomimetics with replacements for hexoses and N-acetyl hexosamines

2008216787-Apparatus and method for administering reduced pressure treatment to a tissue site